期刊文献+

枸橼酸钠抗凝在儿童血液净化中的有效性与安全性研究 被引量:7

Study on the efficacy and safety of sodium citrate anticoagulation in continuous blood purification for children
原文传递
导出
摘要 目的:探讨局部枸橼酸钠抗凝(RCA)技术在儿童血液净化中的有效性和安全性。方法:将43例行连续性血液净化(CBP)治疗的患儿分为肝素抗凝组(20例)和枸橼酸钠抗凝组(23例)。观察两组治疗时间、滤器使用时间,滤器、静脉壶的凝血情况,治疗前及治疗过程中APTT及电解质、血气分析等指标。结果:(1)枸橼酸钠抗凝组平均治疗时间及滤器使用时间均要显著高于肝素抗凝组(P<0.05);(2)枸橼酸钠抗凝组滤器和静脉壶的凝血发生率和严重程度均明显低于肝素抗凝组(P<0.05);(3)枸橼酸抗凝组原有出血加重和新发出血发生率均明显低于肝素抗凝组,枸橼酸纳抗凝组在CBP治疗过程中未见新发出血(P<0.05);(4)肝素抗凝组治疗后APTT明显延长(P<0.05),枸橼酸钠抗凝组治疗前后APTT无明显变化(P>0.05);治疗后,肝素抗凝组较枸橼酸钠抗凝组APTT明显延长(P<0.05);(5)肝素抗凝组治疗前后内环境无明显变化(P>0.05),电解质、酸碱维持在正常范围;枸橼酸钠抗凝组治疗前后Na+、iCa2+I、总钙浓度维持在正常水平(P>0.05),治疗后pH、HCO-3呈逐步上升趋势,治疗12h后出现代谢性碱中毒(P<0.05);两组同一治疗时间点的Na+、iCa2+I、总钙浓度比较差异无统计学意义(P>0.05);治疗8h后,枸橼酸钠抗凝组pH、HCO-3较肝素抗凝组高,枸橼酸钠抗凝组最终有代谢性碱中毒(P<0.05)。结论:RCA在儿童血液净化治疗过程中可获得良好的局部抗凝效果,可以安全有效地用于儿童CBP治疗。 Objective:To discuss effectiveness and safety of sodium citrate anticoagulation in continuous blood purification(CBP)for children.Method:A total of 43 children undergoing CBP treatment were divided into heparin anticoagulation group(20 cases)and sodium citrate anticoagulation group(23 cases).Treatment time,using time of filters,anticoagulation condition in filters and intravenous pots,APTT,electrolyte and blood gas analysis in both groups before treatment and during treatment process were observed.Result:(1)The average treatment time and filter using time in sodium citrate anticoagulation group were significantly higher than that in heparin anticoagulation group(P〈0.05).(2)The anticoagulation occurrence rate in filters and intravenous pots and the severity degree in sodium citrate anticoagulation group were both evidently lower than that in heparin anticoagulation group(P〈0.05).(3)The original bleeding in sodium citrate anticoagulation group was worsening and the occurrence rate of new bleeding was evidently lower than that in heparin anticoagulation group.During CBP process,no new bleeding occurred to child patients in sodium citrate anticoagulation group(P〈0.05).(4)APTT in heparin anticoagulation group after treatment was evidently prolonged(P〈0.05).APTT in sodium citrate anticoagulation group before and after treatment had no evident changes(P〈0.05).Comparing child patients in both groups after treatment,APTT in heparin anticoagulation group was evidently longer than that in sodium citrate anticoagulation group(P〈0.05).(5)In heparin anticoagulation group,internal environment before and after treatment had no evident changes(P〈0.05),electrolyte and power of hydrogen were maintained in the normal range.In sodium citrate anticoagulation group,Na+,iCa2+I,total calcium concentration before and after treatment were maintained in normal range(P〈0.05)and pH,HCO-3 after treatment increased gradually.At 12 hafter treatment,metabolic alkalosis occurred(P〈0.05).Na+,iCa2+Iand total calcium concentration at the same treatment point between two groups were not statistically significant(P〈0.05).pH,HCO-3 of child patients in sodium citrate anticoagulation group at the same treatment time after 2 hwere higher than that in heparin anticoagulation group.Metabolic alkalosis occurred in sodium citrate anticoagulation group finally(P〈0.05).Conclusion:Local sodium citrate anticoagulation has a good local anticoagulation effect during the treatment process of blood purification among children,so it can be used in children CBP treatment safely and effectively.
作者 贺杰 杨梅雨 袁远宏 周雄 彭雅妮 康霞艳 王承娟 宋宇雷 赵文姣 张新萍 肖政辉 HE Jie;YANG Meiyu;YUAN Yuanhong;ZHOU Xiong;PENG Yani;KANG Xiayan;WANG Chengjuan;SONG Yulei;ZHAO Wenjiao;ZHANG Xinping;XIAO Zhenghui(Pediatric Emergency Center,Hunan Children's Hospital,Changsha,410007,China)
出处 《临床急诊杂志》 CAS 2018年第10期667-672,共6页 Journal of Clinical Emergency
基金 儿童急救医学湖南省重点实验室(No:2018TP1028)
关键词 血液净化 枸橼酸钠 抗凝 儿童 blood purification sodium citrate anticoagulation chiidren
  • 相关文献

参考文献7

二级参考文献78

  • 1傅芳婷,张凌.局部枸橼酸抗凝在血液净化治疗中的应用[J].国外医学(移植与血液净化分册),2005,3(6):9-13. 被引量:5
  • 2陆国平,陆铸今,张灵恩,贺骏,胡静,吴芳.脓毒症患儿的持续血液净化治疗22例分析[J].中华儿科杂志,2006,44(8):573-578. 被引量:32
  • 3封志纯,常平,陶少华,陈慧.连续血液净化治疗儿童脓毒性休克[J].中华儿科杂志,2006,44(8):579-582. 被引量:18
  • 4樊寻梅.儿科感染性休克(脓毒性休克)诊疗推荐方案[J].中华儿科杂志,2006,44(8):596-598. 被引量:205
  • 5Palsson R,Niles JL.Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding.Kidney Int,1999,55:1991
  • 6Tolwani JA,Campbell RC,Schenk MB et al.Simplified citrate anticoagulation for continuous renal replacement therapy.Kidney Int,2001,60:370
  • 7Janssen MJ,Huijgens PC,Bouman AA et al.Citrate versus heparin anticoagulation in chronic hemodialysis patients.Nephrol Dial Transplant,1993,8(11):1228
  • 8Kirschbaum B,Galishoff M,Reines HD.Lactic acidosis treated with continuous hemodiafiltration and regional citrate anticoagulation.Crit Care Med,1992,20(3):349
  • 9Meulen JVD,Janssen MJFM,Langendijk PNJ et al.Citrate anticoagulation and dialysate with reduced buffer content in chronic hemodialysis.Clin Nephrol,1991,37(1):36
  • 10Kutsogiannis DJ,Mayers I,Chin WDN et al.Regional citrate anticoagulation in continuous venovenous hemodiafiltration.Am J Kidney Dis,2000,35(5):802

共引文献230

同被引文献71

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部